Yun Wang

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Topics

Multiple Myeloma

Sensitive Detection

Newly Diagnosed

Ejection Fraction

Top Venues

Clinical and experimental immunology

Disease markers

Annals of hematology

BioMed research international

This page only lists publications with an associated author ORCID identifier.

Publications

Pei Guo, Yun Wang, Haiyan He, Dongjian Chen, Jin Liu, Wanting Qiang, Jing Lu, Yang Liang, Juan Du
Elevated serum levels of soluble B-cell maturation antigen as a prognostic biomarker for multiple myeloma. Clinical and experimental immunology (2024)
Pei Guo, Yun Wang, Haiyan He, Dongjian Chen, Jin Liu, Wanting Qiang, Jing Lu, Yang Liang, Juan Du
Elevated serum levels of soluble B-cell maturation antigen as a prognostic biomarker for multiple myeloma. Clinical and experimental immunology 217 (3) (2024)
Pei Guo, Yun Wang, Haiyan He, Dongjian Chen, Jin Liu, Wanting Qiang, Jing Lu, Yang Liang, Juan Du
Elevated serum levels of soluble B-cell maturation antigen as a prognostic biomarker for multiple myeloma. Clinical and experimental immunology 217 (3) (2024)
Pei Guo, Yun Wang, Haiyan He, Dongjian Chen, Jin Liu, Wanting Qiang, Jing Lu, Yang Liang, Juan Du
Elevated serum levels of soluble B-cell maturation antigen as a prognostic biomarker for multiple myeloma. Clinical and experimental immunology 217 (3) (2024)
Limei Zhang, Shuzhao Chen, Mayan Huang, Weida Wang, Yang Liang, Yun Wang
Prognostic value of the nutritional risk index in patients with newly diagnosed multiple myeloma. Annals of hematology (2022)
Run-Cong Nie, Chong-Bang Zhao, Xiao-Wei Xia, Ying-Shan Luo, Ting Wu, Zhi-Wei Zhou, Shu-Qiang Yuan, Yun Wang, Yuan-Fang Li
The Efficacy and Safety of PD-1/PD-L1 Inhibitors in Combination with Conventional Therapies for Advanced Solid Tumors: A Meta-Analysis. BioMed research international 2020 (2020)
Xiao-Jiang Chen, Shu-Qiang Yuan, Jin-Ling Duan, Yong-Ming Chen, Shi Chen, Yun Wang, Yuan-Fang Li
The Value of PD-L1 Expression in Predicting the Efficacy of Anti-PD-1 or Anti-PD-L1 Therapy in Patients with Cancer: A Systematic Review and Meta-Analysis. Disease markers 2020 (2020)